Source Name	Characteristics[organism]	Characteristics[organism part]	Characteristics[age]	Characteristics[sex]	Characteristics[disease]	Characteristics[ancestry category]	Characteristics[cell type]	Characteristics[cell line]	Characteristics[enrichment process]	Characteristics[biological replicate]	assay name	comment[data file]	comment[file uri]	comment[technical replicate]	comment[fraction identifier]	comment[label]	comment[cleavage agent details]	comment[instrument]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[dissociation method]	comment[collision energy]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	factor value[cell line]	factor value[compound]	Material Type	Factor Value[compound]
Sample 1	Homo sapiens	B lymphocyte	38Y	male	Transformed follicular lymphoma	Caucasian	B lymphocyte	SU-DHL-4	glycosylation	1	run 1	UM_2009_1432a-SUDHL4.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_1432a-SUDHL4.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SU-DHL-4	None	cell	None
Sample 1	Homo sapiens	B lymphocyte	38Y	male	Transformed follicular lymphoma	Caucasian	B lymphocyte	SU-DHL-4	glycosylation	1	run 2	UM_2009_1432b-SUDHL4.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_1432b-SUDHL4.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SU-DHL-4	None	cell	None
Sample 1	Homo sapiens	B lymphocyte	38Y	male	Transformed follicular lymphoma	Caucasian	B lymphocyte	SU-DHL-4	glycosylation	1	run 3	UM_2009_1432c-SUDHL4.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_1432c-SUDHL4.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SU-DHL-4	None	cell	None
Sample 2	Homo sapiens	thyroid	71Y	male	Classical Hodgkin lymphoma	not available	not available	KMH2	glycosylation	1	run 4	UM_2009_1433a-KMH2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_1433a-KMH2.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMH2	None	cell	None
Sample 2	Homo sapiens	thyroid	71Y	male	Classical Hodgkin lymphoma	not available	not available	KMH2	glycosylation	1	run 5	UM_2009_1433b-KMH2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_1433b-KMH2.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMH2	None	cell	None
Sample 2	Homo sapiens	thyroid	71Y	male	Classical Hodgkin lymphoma	not available	not available	KMH2	glycosylation	1	run 6	UM_2009_1433c-KMH2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_1433c-KMH2.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMH2	None	cell	None
Sample 3	Homo sapiens	lymphoblast	38Y	male	Transformed follicular lymphoma	Caucasian	B lymphocyte	SU-DHL-4	glycosylation	2	run 7	UM_2009_1603_a-SUDHL4.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_1603_a-SUDHL4.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SU-DHL-4	None	cell	None
Sample 3	Homo sapiens	lymphoblast	38Y	male	Transformed follicular lymphoma	Caucasian	B lymphocyte	SU-DHL-4	glycosylation	2	run 8	UM_2009_1603_b-SUDHL4.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_1603_b-SUDHL4.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SU-DHL-4	None	cell	None
Sample 3	Homo sapiens	lymphoblast	38Y	male	Transformed follicular lymphoma	Caucasian	B lymphocyte	SU-DHL-4	glycosylation	2	run 9	UM_2009_1603_c-SUDHL4.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_1603_c-SUDHL4.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SU-DHL-4	None	cell	None
Sample 4	Homo sapiens	thyroid	71Y	male	Classical Hodgkin lymphoma	not available	not available	KMH2	glycosylation	2	run 10	UM_2009_1604_a-KMH2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_1604_a-KMH2.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMH2	None	cell	None
Sample 4	Homo sapiens	thyroid	71Y	male	Classical Hodgkin lymphoma	not available	not available	KMH2	glycosylation	2	run 11	UM_2009_1604_b-KMH2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_1604_b-KMH2.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMH2	None	cell	None
Sample 4	Homo sapiens	thyroid	71Y	male	Classical Hodgkin lymphoma	not available	not available	KMH2	glycosylation	2	run 12	UM_2009_1604_c-KMH2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_1604_c-KMH2.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMH2	None	cell	None
Sample 5	Homo sapiens	thyroid	71Y	male	Classical Hodgkin lymphoma	not available	not available	KMH2	glycosylation	3	run 13	UM_2009_1778_a-KMH2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_1778_a-KMH2.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMH2	None	cell	None
Sample 5	Homo sapiens	thyroid	71Y	male	Classical Hodgkin lymphoma	not available	not available	KMH2	glycosylation	3	run 14	UM_2009_1778_b-KMH2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_1778_b-KMH2.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMH2	None	cell	None
Sample 5	Homo sapiens	thyroid	71Y	male	Classical Hodgkin lymphoma	not available	not available	KMH2	glycosylation	3	run 15	UM_2009_1778_c-KMH2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_1778_c-KMH2.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMH2	None	cell	None
Sample 6	Homo sapiens	lymphoblast	38Y	male	Transformed follicular lymphoma	Caucasian	B lymphocyte	SU-DHL-4	glycosylation	3	run 16	UM_2009_a_1383-SUDHL4.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_a_1383-SUDHL4.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SU-DHL-4	None	cell	None
Sample 6	Homo sapiens	lymphoblast	38Y	male	Transformed follicular lymphoma	Caucasian	B lymphocyte	SU-DHL-4	glycosylation	3	run 17	UM_2009_A_2098_a1-SUDHL1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2098_a1-SUDHL1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SU-DHL-4	None	cell	None
Sample 6	Homo sapiens	lymphoblast	38Y	male	Transformed follicular lymphoma	Caucasian	B lymphocyte	SU-DHL-4	glycosylation	3	run 18	UM_2009_A_2098_a2-SUDHL1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2098_a2-SUDHL1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SU-DHL-4	None	cell	None
Sample 7	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	1	run 19	UM_2009_A_2098_a3-SUDHL1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2098_a3-SUDHL1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	None	cell	None
Sample 7	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	1	run 20	UM_2009_A_2099_a1-MEDB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2099_a1-MEDB1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	None	cell	None
Sample 7	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	1	run 21	UM_2009_A_2099_a2-MEDB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2099_a2-MEDB1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	None	cell	None
Sample 8	Homo sapiens	lymphoblast	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B lymphocyte	Med-B1	glycosylation	1	run 22	UM_2009_A_2099_a3-MEDB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2099_a3-MEDB1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Med-B1	None	cell	None
Sample 8	Homo sapiens	lymphoblast	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B lymphocyte	Med-B1	glycosylation	1	run 23	UM_2009_A_2100_a1-DEL.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2100_a1-DEL.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Med-B1	None	cell	None
Sample 8	Homo sapiens	lymphoblast	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B lymphocyte	Med-B1	glycosylation	1	run 24	UM_2009_A_2100_a2-DEL.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2100_a2-DEL.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Med-B1	None	cell	None
Sample 9	Homo sapiens	not available	not available	not available	Anaplastic large cell lymphoma	not available	not available	DEL	glycosylation	1	run 25	UM_2009_A_2100_a3-DEL.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2100_a3-DEL.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEL	None	cell	None
Sample 9	Homo sapiens	not available	not available	not available	Anaplastic large cell lymphoma	not available	not available	DEL	glycosylation	1	run 26	UM_2009_A_2233_a1-DEL.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2233_a1-DEL.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEL	None	cell	None
Sample 9	Homo sapiens	not available	not available	not available	Anaplastic large cell lymphoma	not available	not available	DEL	glycosylation	1	run 27	UM_2009_A_2233_a2-DEL.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2233_a2-DEL.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEL	None	cell	None
Sample 10	Homo sapiens	not available	not available	not available	Anaplastic large cell lymphoma	not available	not available	DEL	glycosylation	2	run 28	UM_2009_A_2233_a3-DEL.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2233_a3-DEL.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEL	None	cell	None
Sample 10	Homo sapiens	not available	not available	not available	Anaplastic large cell lymphoma	not available	not available	DEL	glycosylation	2	run 29	UM_2009_A_2234_a1-KARPAS1106P.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2234_a1-KARPAS1106P.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEL	None	cell	None
Sample 10	Homo sapiens	not available	not available	not available	Anaplastic large cell lymphoma	not available	not available	DEL	glycosylation	2	run 30	UM_2009_A_2234_a2-KARPAS1106P.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2234_a2-KARPAS1106P.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEL	None	cell	None
Sample 11	Homo sapiens	Blood	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B cell lymphoma	Karpas 1106P	glycosylation	1	run 31	UM_2009_A_2234_a3-KARPAS1106P.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2234_a3-KARPAS1106P.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 1106P	None	cell	None
Sample 11	Homo sapiens	Blood	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B cell lymphoma	Karpas 1106P	glycosylation	1	run 32	UM_2009_A_2479_a1-DEL.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2479_a1-DEL.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 1106P	None	cell	None
Sample 11	Homo sapiens	Blood	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B cell lymphoma	Karpas 1106P	glycosylation	1	run 33	UM_2009_A_2479_a2-DEL.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2479_a2-DEL.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 1106P	None	cell	None
Sample 12	Homo sapiens	not available	not available	not available	Anaplastic large cell lymphoma	not available	not available	DEL	glycosylation	3	run 34	UM_2009_A_2479_a3-DEL.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2479_a3-DEL.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEL	None	cell	None
Sample 12	Homo sapiens	not available	not available	not available	Anaplastic large cell lymphoma	not available	not available	DEL	glycosylation	3	run 35	UM_2009_A_2544_a1-SUDHL1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2544_a1-SUDHL1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEL	None	cell	None
Sample 12	Homo sapiens	not available	not available	not available	Anaplastic large cell lymphoma	not available	not available	DEL	glycosylation	3	run 36	UM_2009_A_2544_a2-SUDHL1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2544_a2-SUDHL1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEL	None	cell	None
Sample 13	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	2	run 37	UM_2009_A_2544_a3-SUDHL1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2544_a3-SUDHL1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	None	cell	None
Sample 13	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	2	run 38	UM_2009_A_2561_a1-L428.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2561_a1-L428.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	None	cell	None
Sample 13	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	2	run 39	UM_2009_A_2561_a2-L428.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2561_a2-L428.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	None	cell	None
Sample 14	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	not available	L428	glycosylation	1	run 40	UM_2009_A_2561_a3-L428.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2561_a3-L428.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L428	None	cell	None
Sample 14	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	not available	L428	glycosylation	1	run 41	UM_2009_A_2562_a1-MEDB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2562_a1-MEDB1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L428	None	cell	None
Sample 14	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	not available	L428	glycosylation	1	run 42	UM_2009_A_2562_a2-MEDB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2562_a2-MEDB1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L428	None	cell	None
Sample 15	Homo sapiens	lymphoblast	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B lymphocyte	Med-B1	glycosylation	2	run 43	UM_2009_A_2562_a3-MEDB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2562_a3-MEDB1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Med-B1	None	cell	None
Sample 15	Homo sapiens	lymphoblast	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B lymphocyte	Med-B1	glycosylation	2	run 44	UM_2009_A_2677_a1-SUDHL1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2677_a1-SUDHL1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Med-B1	None	cell	None
Sample 15	Homo sapiens	lymphoblast	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B lymphocyte	Med-B1	glycosylation	2	run 45	UM_2009_A_2677_a2-SUDHL1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2677_a2-SUDHL1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Med-B1	None	cell	None
Sample 16	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	3	run 46	UM_2009_A_2677_a3-SUDHL1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2677_a3-SUDHL1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	None	cell	None
Sample 16	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	3	run 47	UM_2009_A_2678_a1-OCILY2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2678_a1-OCILY2.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	None	cell	None
Sample 16	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	3	run 48	UM_2009_A_2678_a2-OCILY2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2678_a2-OCILY2.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	None	cell	None
Sample 17	Homo sapiens	lymph node	not available	not available	Diffuse large B-cell lymphoma	not available	not available	OCI-Ly2	glycosylation	1	run 49	UM_2009_A_2678_a3-OCILY2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2678_a3-OCILY2.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly2	None	cell	None
Sample 17	Homo sapiens	lymph node	not available	not available	Diffuse large B-cell lymphoma	not available	not available	OCI-Ly2	glycosylation	1	run 50	UM_2009_A_2764_a1-L428.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2764_a1-L428.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly2	None	cell	None
Sample 17	Homo sapiens	lymph node	not available	not available	Diffuse large B-cell lymphoma	not available	not available	OCI-Ly2	glycosylation	1	run 51	UM_2009_A_2764_a2-L428.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2764_a2-L428.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly2	None	cell	None
Sample 18	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	not available	L428	glycosylation	2	run 52	UM_2009_A_2764_a3-L428.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2764_a3-L428.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L428	None	cell	None
Sample 18	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	not available	L428	glycosylation	2	run 53	UM_2009_A_2765_a1-MEDB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2765_a1-MEDB1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L428	None	cell	None
Sample 18	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	not available	L428	glycosylation	2	run 54	UM_2009_A_2765_a2-MEDB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2765_a2-MEDB1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L428	None	cell	None
Sample 19	Homo sapiens	B lymphocyte	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B lymphocyte	Med-B1	glycosylation	3	run 55	UM_2009_A_2765_a3-MEDB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2765_a3-MEDB1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Med-B1	None	cell	None
Sample 19	Homo sapiens	B lymphocyte	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B lymphocyte	Med-B1	glycosylation	3	run 56	UM_2009_A_2823_a1-L428.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2823_a1-L428.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Med-B1	None	cell	None
Sample 19	Homo sapiens	B lymphocyte	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B lymphocyte	Med-B1	glycosylation	3	run 57	UM_2009_A_2823_a2-L428.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2823_a2-L428.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Med-B1	None	cell	None
Sample 20	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	not available	L428	glycosylation	3	run 58	UM_2009_A_2823_a3-L428.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2823_a3-L428.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L428	None	cell	None
Sample 20	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	not available	L428	glycosylation	3	run 59	UM_2009_A_2824_a1-KARPAS1106P.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2824_a1-KARPAS1106P.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L428	None	cell	None
Sample 20	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	not available	L428	glycosylation	3	run 60	UM_2009_A_2824_a2-KARPAS1106P.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2824_a2-KARPAS1106P.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L428	None	cell	None
Sample 21	Homo sapiens	Blood	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B cell lymphoma	Karpas 1106P	glycosylation	2	run 61	UM_2009_A_2824_a3-KARPAS1106P.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2824_a3-KARPAS1106P.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 1106P	None	cell	None
Sample 21	Homo sapiens	Blood	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B cell lymphoma	Karpas 1106P	glycosylation	2	run 62	UM_2009_A_2881_a1-KARPAS1106P.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2881_a1-KARPAS1106P.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 1106P	None	cell	None
Sample 21	Homo sapiens	Blood	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B cell lymphoma	Karpas 1106P	glycosylation	2	run 63	UM_2009_A_2881_a2-KARPAS1106P.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2881_a2-KARPAS1106P.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 1106P	None	cell	None
Sample 22	Homo sapiens	Blood	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B cell lymphoma	Karpas 1106P	glycosylation	3	run 64	UM_2009_A_2881_a3-KARPAS1106P.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2881_a3-KARPAS1106P.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 1106P	None	cell	None
Sample 22	Homo sapiens	Blood	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B cell lymphoma	Karpas 1106P	glycosylation	3	run 65	UM_2009_A_2914_a1-NCEB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2914_a1-NCEB1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 1106P	None	cell	None
Sample 22	Homo sapiens	Blood	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B cell lymphoma	Karpas 1106P	glycosylation	3	run 66	UM_2009_A_2914_a2-NCEB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2914_a2-NCEB1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 1106P	None	cell	None
Sample 23	Homo sapiens	peripheral blood	57Y	not available	lymphoma	not available	lymphoblast	NCEB-1	glycosylation	1	run 67	UM_2009_A_2914_a3-NCEB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2914_a3-NCEB1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NCEB-1	None	cell	None
Sample 23	Homo sapiens	peripheral blood	57Y	not available	lymphoma	not available	lymphoblast	NCEB-1	glycosylation	1	run 68	UM_2009_A_2915_a1-FL218.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2915_a1-FL218.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NCEB-1	None	cell	None
Sample 23	Homo sapiens	peripheral blood	57Y	not available	lymphoma	not available	lymphoblast	NCEB-1	glycosylation	1	run 69	UM_2009_A_2915_a2-FL218.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2915_a2-FL218.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NCEB-1	None	cell	None
Sample 24	Homo sapiens	lymphoblast	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-218	glycosylation	1	run 70	UM_2009_A_2915_a3-FL218.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2915_a3-FL218.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-218	None	cell	None
Sample 24	Homo sapiens	lymphoblast	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-218	glycosylation	1	run 71	UM_2009_A_2916_a1-FL218.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2916_a1-FL218.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-218	None	cell	None
Sample 24	Homo sapiens	lymphoblast	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-218	glycosylation	1	run 72	UM_2009_A_2916_a2-FL218.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2916_a2-FL218.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-218	None	cell	None
Sample 25	Homo sapiens	lymphoblast	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-218	glycosylation	2	run 73	UM_2009_A_2916_a3-FL218.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2916_a3-FL218.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-218	None	cell	None
Sample 25	Homo sapiens	lymphoblast	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-218	glycosylation	2	run 74	UM_2009_A_2918_a1-OCILY2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2918_a1-OCILY2.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-218	None	cell	None
Sample 25	Homo sapiens	lymphoblast	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-218	glycosylation	2	run 75	UM_2009_A_2918_a2-OCILY2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2918_a2-OCILY2.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-218	None	cell	None
Sample 26	Homo sapiens	lymph node	not available	not available	Diffuse large B-cell lymphoma	not available	not available	OCI-Ly2	glycosylation	2	run 76	UM_2009_A_2918_a3-OCILY2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2918_a3-OCILY2.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly2	None	cell	None
Sample 26	Homo sapiens	lymph node	not available	not available	Diffuse large B-cell lymphoma	not available	not available	OCI-Ly2	glycosylation	2	run 77	UM_2009_A_2920_a1-NCEB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2920_a1-NCEB1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly2	None	cell	None
Sample 26	Homo sapiens	lymph node	not available	not available	Diffuse large B-cell lymphoma	not available	not available	OCI-Ly2	glycosylation	2	run 78	UM_2009_A_2920_a2-NCEB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2920_a2-NCEB1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly2	None	cell	None
Sample 27	Homo sapiens	peripheral blood	57Y	not available	lymphoma	not available	lymphoblast	NCEB-1	glycosylation	2	run 79	UM_2009_A_2920_a3-NCEB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2920_a3-NCEB1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NCEB-1	None	cell	None
Sample 27	Homo sapiens	peripheral blood	57Y	not available	lymphoma	not available	lymphoblast	NCEB-1	glycosylation	2	run 80	UM_2009_A_3210_a1-RAMOS.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3210_a1-RAMOS.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NCEB-1	None	cell	None
Sample 27	Homo sapiens	peripheral blood	57Y	not available	lymphoma	not available	lymphoblast	NCEB-1	glycosylation	2	run 81	UM_2009_A_3210_a2-RAMOS.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3210_a2-RAMOS.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NCEB-1	None	cell	None
Sample 28	Homo sapiens	lymphoblast	3Y	male	Burkitt's lymphoma (American)	Caucasian	B lymphocyte	Ramos	glycosylation	1	run 82	UM_2009_A_3210_a3-RAMOS.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3210_a3-RAMOS.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Ramos	None	cell	None
Sample 28	Homo sapiens	lymphoblast	3Y	male	Burkitt's lymphoma (American)	Caucasian	B lymphocyte	Ramos	glycosylation	1	run 83	UM_2009_A_3240_a3-RAMOS.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3240_a3-RAMOS.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Ramos	None	cell	None
Sample 28	Homo sapiens	lymphoblast	3Y	male	Burkitt's lymphoma (American)	Caucasian	B lymphocyte	Ramos	glycosylation	1	run 84	UM_2009_A_3240_a4-RAMOS.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3240_a4-RAMOS.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Ramos	None	cell	None
Sample 29	Homo sapiens	lymphoblast	3Y	male	Burkitt's lymphoma (American)	Caucasian	B lymphocyte	Ramos	glycosylation	2	run 85	UM_2009_A_3240_a5-RAMOS.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3240_a5-RAMOS.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Ramos	None	cell	None
Sample 29	Homo sapiens	lymphoblast	3Y	male	Burkitt's lymphoma (American)	Caucasian	B lymphocyte	Ramos	glycosylation	2	run 86	UM_2009_A_3241_a1-DEV.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3241_a1-DEV.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Ramos	None	cell	None
Sample 29	Homo sapiens	lymphoblast	3Y	male	Burkitt's lymphoma (American)	Caucasian	B lymphocyte	Ramos	glycosylation	2	run 87	UM_2009_A_3241_a2-DEV.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3241_a2-DEV.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Ramos	None	cell	None
Sample 30	Homo sapiens	lymphoblast	not available	not available	Nodular lymphocyte predominant Hodgkin lymphoma	not available	B lymphocyte	DEV	glycosylation	1	run 88	UM_2009_A_3241_a3-DEV.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3241_a3-DEV.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEV	None	cell	None
Sample 30	Homo sapiens	lymphoblast	not available	not available	Nodular lymphocyte predominant Hodgkin lymphoma	not available	B lymphocyte	DEV	glycosylation	1	run 89	UM_2009_A_3242_a1-DEV.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3242_a1-DEV.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEV	None	cell	None
Sample 30	Homo sapiens	lymphoblast	not available	not available	Nodular lymphocyte predominant Hodgkin lymphoma	not available	B lymphocyte	DEV	glycosylation	1	run 90	UM_2009_A_3242_a2-DEV.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3242_a2-DEV.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEV	None	cell	None
Sample 31	Homo sapiens	lymphoblast	not available	not available	Nodular lymphocyte predominant Hodgkin lymphoma	not available	B lymphocyte	DEV	glycosylation	2	run 91	UM_2009_A_3242_a3-DEV.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3242_a3-DEV.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEV	None	cell	None
Sample 31	Homo sapiens	lymphoblast	not available	not available	Nodular lymphocyte predominant Hodgkin lymphoma	not available	B lymphocyte	DEV	glycosylation	2	run 92	UM_2009_A_3245_a1-NCEB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3245_a1-NCEB1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEV	None	cell	None
Sample 31	Homo sapiens	lymphoblast	not available	not available	Nodular lymphocyte predominant Hodgkin lymphoma	not available	B lymphocyte	DEV	glycosylation	2	run 93	UM_2009_A_3245_a2-NCEB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3245_a2-NCEB1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEV	None	cell	None
Sample 32	Homo sapiens	peripheral blood	57Y	not available	lymphoma	not available	lymphoblast	NCEB-1	glycosylation	3	run 94	UM_2009_A_3245_a3-NCEB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3245_a3-NCEB1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NCEB-1	None	cell	None
Sample 32	Homo sapiens	peripheral blood	57Y	not available	lymphoma	not available	lymphoblast	NCEB-1	glycosylation	3	run 95	UM_2009_A_3385_a1-OCILY2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3385_a1-OCILY2.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NCEB-1	None	cell	None
Sample 32	Homo sapiens	peripheral blood	57Y	not available	lymphoma	not available	lymphoblast	NCEB-1	glycosylation	3	run 96	UM_2009_A_3385_a2-OCILY2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3385_a2-OCILY2.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NCEB-1	None	cell	None
Sample 33	Homo sapiens	lymph node	not available	not available	Diffuse large B-cell lymphoma	not available	not available	OCI-Ly2	glycosylation	3	run 97	UM_2009_A_3385_a3-OCILY2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3385_a3-OCILY2.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly2	None	cell	None
Sample 33	Homo sapiens	lymph node	not available	not available	Diffuse large B-cell lymphoma	not available	not available	OCI-Ly2	glycosylation	3	run 98	UM_2009_A_3447_a1-FL218.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3447_a1-FL218.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly2	None	cell	None
Sample 33	Homo sapiens	lymph node	not available	not available	Diffuse large B-cell lymphoma	not available	not available	OCI-Ly2	glycosylation	3	run 99	UM_2009_A_3447_a2-FL218.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3447_a2-FL218.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly2	None	cell	None
Sample 34	Homo sapiens	lymphoblast	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-218	glycosylation	3	run 100	UM_2009_A_3447_a3-FL218.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3447_a3-FL218.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-218	None	cell	None
Sample 34	Homo sapiens	lymphoblast	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-218	glycosylation	3	run 101	UM_2009_A_3494_a1-RAJI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3494_a1-RAJI.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-218	None	cell	None
Sample 34	Homo sapiens	lymphoblast	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-218	glycosylation	3	run 102	UM_2009_A_3494_a2-RAJI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3494_a2-RAJI.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-218	None	cell	None
Sample 35	Homo sapiens	lymphoblast	11Y	male	Burkitt's lymphoma	Black	B lymphocyte	Raji	glycosylation	1	run 103	UM_2009_A_3494_a3-RAJI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3494_a3-RAJI.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Raji	None	cell	None
Sample 35	Homo sapiens	lymphoblast	11Y	male	Burkitt's lymphoma	Black	B lymphocyte	Raji	glycosylation	1	run 104	UM_2009_A_3495_a1-RAJI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3495_a1-RAJI.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Raji	None	cell	None
Sample 35	Homo sapiens	lymphoblast	11Y	male	Burkitt's lymphoma	Black	B lymphocyte	Raji	glycosylation	1	run 105	UM_2009_A_3495_a2-RAJI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3495_a2-RAJI.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Raji	None	cell	None
Sample 36	Homo sapiens	lymphoblast	11Y	male	Burkitt's lymphoma	Black	B lymphocyte	Raji	glycosylation	2	run 106	UM_2009_A_3495_a3-RAJI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3495_a3-RAJI.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Raji	None	cell	None
Sample 36	Homo sapiens	lymphoblast	11Y	male	Burkitt's lymphoma	Black	B lymphocyte	Raji	glycosylation	2	run 107	UM_2009_b_1383-SUDHL4.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_b_1383-SUDHL4.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Raji	None	cell	None
Sample 36	Homo sapiens	lymphoblast	11Y	male	Burkitt's lymphoma	Black	B lymphocyte	Raji	glycosylation	2	run 108	UM_2009_c_1383-SUDHL4.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_c_1383-SUDHL4.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Raji	None	cell	None
Sample 37	Homo sapiens	Blood	not available	not available	Mantle cell lymphoma	not available	B lymphocyte	Granta 519	glycosylation	1	run 109	UM_2010_A_0003_a1-GRANTA519.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2010_A_0003_a1-GRANTA519.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Granta 519	None	cell	None
Sample 37	Homo sapiens	Blood	not available	not available	Mantle cell lymphoma	not available	B lymphocyte	Granta 519	glycosylation	1	run 110	UM_2010_A_0003_a2-GRANTA519.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2010_A_0003_a2-GRANTA519.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Granta 519	None	cell	None
Sample 37	Homo sapiens	Blood	not available	not available	Mantle cell lymphoma	not available	B lymphocyte	Granta 519	glycosylation	1	run 111	UM_2010_A_0003_a3-GRANTA519.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2010_A_0003_a3-GRANTA519.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Granta 519	None	cell	None
Sample 38	Homo sapiens	lymphoblast	not available	not available	Nodular lymphocyte predominant Hodgkin lymphoma	not available	B lymphocyte	DEV	glycosylation	3	run 112	UM_A_2009_3243_a1-DEV.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2009_3243_a1-DEV.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEV	None	cell	None
Sample 38	Homo sapiens	lymphoblast	not available	not available	Nodular lymphocyte predominant Hodgkin lymphoma	not available	B lymphocyte	DEV	glycosylation	3	run 113	UM_A_2009_3243_a2-DEV.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2009_3243_a2-DEV.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEV	None	cell	None
Sample 38	Homo sapiens	lymphoblast	not available	not available	Nodular lymphocyte predominant Hodgkin lymphoma	not available	B lymphocyte	DEV	glycosylation	3	run 114	UM_A_2009_3243_a3-DEV.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2009_3243_a3-DEV.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEV	None	cell	None
Sample 39	Homo sapiens	lymphoblast	3Y	male	Burkitt's lymphoma (American)	Caucasian	B lymphocyte	Ramos	glycosylation	3	run 115	UM_A_2009_3249_a1-RAMOS.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2009_3249_a1-RAMOS.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Ramos	None	cell	None
Sample 39	Homo sapiens	lymphoblast	3Y	male	Burkitt's lymphoma (American)	Caucasian	B lymphocyte	Ramos	glycosylation	3	run 116	UM_A_2009_3249_a2-RAMOS.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2009_3249_a2-RAMOS.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Ramos	None	cell	None
Sample 39	Homo sapiens	lymphoblast	3Y	male	Burkitt's lymphoma (American)	Caucasian	B lymphocyte	Ramos	glycosylation	3	run 117	UM_A_2009_3249_a3-RAMOS.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2009_3249_a3-RAMOS.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Ramos	None	cell	None
Sample 40	Homo sapiens	lymphoblast	11Y	male	Burkitt's lymphoma	Black	B lymphocyte	Raji	glycosylation	3	run 118	UM_A_2009_3388_a1-RAJI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2009_3388_a1-RAJI.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Raji	None	cell	None
Sample 40	Homo sapiens	lymphoblast	11Y	male	Burkitt's lymphoma	Black	B lymphocyte	Raji	glycosylation	3	run 119	UM_A_2009_3388_a2-RAJI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2009_3388_a2-RAJI.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Raji	None	cell	None
Sample 40	Homo sapiens	lymphoblast	11Y	male	Burkitt's lymphoma	Black	B lymphocyte	Raji	glycosylation	3	run 120	UM_A_2009_3388_a3-RAJI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2009_3388_a3-RAJI.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Raji	None	cell	None
Sample 41	Homo sapiens	Blood	not available	not available	Mantle cell lymphoma	not available	B lymphocyte	Granta 519	glycosylation	2	run 121	UM_A_2010_0004_a1-GRANTA519.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2010_0004_a1-GRANTA519.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Granta 519	None	cell	None
Sample 41	Homo sapiens	Blood	not available	not available	Mantle cell lymphoma	not available	B lymphocyte	Granta 519	glycosylation	2	run 122	UM_A_2010_0004_a2-GRANTA519.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2010_0004_a2-GRANTA519.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Granta 519	None	cell	None
Sample 41	Homo sapiens	Blood	not available	not available	Mantle cell lymphoma	not available	B lymphocyte	Granta 519	glycosylation	2	run 123	UM_A_2010_0004_a3-GRANTA519.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2010_0004_a3-GRANTA519.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Granta 519	None	cell	None
Sample 42	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	Lymphocyte	L1236	glycosylation	1	run 124	UM_A_2010_0005_a1-L1236.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2010_0005_a1-L1236.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L1236	None	cell	None
Sample 42	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	Lymphocyte	L1236	glycosylation	1	run 125	UM_A_2010_0005_a2-L1236.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2010_0005_a2-L1236.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L1236	None	cell	None
Sample 42	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	Lymphocyte	L1236	glycosylation	1	run 126	UM_A_2010_0005_a3-L1236.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2010_0005_a3-L1236.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L1236	None	cell	None
Sample 43	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	Lymphocyte	L1236	glycosylation	2	run 127	UM_A_2010_0007_a1-L1236.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2010_0007_a1-L1236.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L1236	None	cell	None
Sample 43	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	Lymphocyte	L1236	glycosylation	2	run 128	UM_A_2010_0007_a2-L1236.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2010_0007_a2-L1236.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L1236	None	cell	None
Sample 43	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	Lymphocyte	L1236	glycosylation	2	run 129	UM_A_2010_0007_a3-L1236.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2010_0007_a3-L1236.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L1236	None	cell	None
Sample 44	Homo sapiens	Blood	not available	not available	Mantle cell lymphoma	not available	B lymphocyte	Granta 519	glycosylation	3	run 130	UM_A_2010_0012_a1-GRANTA519.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2010_0012_a1-GRANTA519.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Granta 519	None	cell	None
Sample 44	Homo sapiens	Blood	not available	not available	Mantle cell lymphoma	not available	B lymphocyte	Granta 519	glycosylation	3	run 131	UM_A_2010_0012_a2-GRANTA519.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2010_0012_a2-GRANTA519.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Granta 519	None	cell	None
Sample 44	Homo sapiens	Blood	not available	not available	Mantle cell lymphoma	not available	B lymphocyte	Granta 519	glycosylation	3	run 132	UM_A_2010_0012_a3-GRANTA519.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2010_0012_a3-GRANTA519.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Granta 519	None	cell	None
Sample 45	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	Lymphocyte	L1236	glycosylation	3	run 133	UM_A_2010_0013_a1-L1236.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2010_0013_a1-L1236.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L1236	None	cell	None
Sample 45	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	Lymphocyte	L1236	glycosylation	3	run 134	UM_A_2010_0013_a2-L1236.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2010_0013_a2-L1236.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L1236	None	cell	None
Sample 45	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	Lymphocyte	L1236	glycosylation	3	run 135	UM_A_2010_0013_a3-L1236.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2010_0013_a3-L1236.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L1236	None	cell	None
Sample 46	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-18	glycosylation	1	run 136	UM_A_2011_0276_a1-FL18.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0276_a1-FL18.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-18	None	cell	None
Sample 46	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-18	glycosylation	1	run 137	UM_A_2011_0276_a2-FL18.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0276_a2-FL18.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-18	None	cell	None
Sample 46	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-18	glycosylation	1	run 138	UM_A_2011_0276_a3-FL18.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0276_a3-FL18.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-18	None	cell	None
Sample 47	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-318	glycosylation	1	run 139	UM_A_2011_0277_a1-FL318.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0277_a1-FL318.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-318	None	cell	None
Sample 47	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-318	glycosylation	1	run 140	UM_A_2011_0277_a2-FL318.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0277_a2-FL318.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-318	None	cell	None
Sample 47	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-318	glycosylation	1	run 141	UM_A_2011_0277_a3-FL318.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0277_a3-FL318.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-318	None	cell	None
Sample 48	Homo sapiens	lymph node	not available	not available	Burkitt lymphoma	not available	B lymphocyte	BJA-B	glycosylation	1	run 142	UM_A_2011_0316_a1-BJAB.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0316_a1-BJAB.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	BJA-B	None	cell	None
Sample 48	Homo sapiens	lymph node	not available	not available	Burkitt lymphoma	not available	B lymphocyte	BJA-B	glycosylation	1	run 143	UM_A_2011_0316_a2-BJAB.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0316_a2-BJAB.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	BJA-B	None	cell	None
Sample 48	Homo sapiens	lymph node	not available	not available	Burkitt lymphoma	not available	B lymphocyte	BJA-B	glycosylation	1	run 144	UM_A_2011_0316_a3-BJAB.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0316_a3-BJAB.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	BJA-B	None	cell	None
Sample 49	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-318	glycosylation	2	run 145	UM_A_2011_0318_a1-FL318.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0318_a1-FL318.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-318	None	cell	None
Sample 49	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-318	glycosylation	2	run 146	UM_A_2011_0318_a2-FL318.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0318_a2-FL318.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-318	None	cell	None
Sample 49	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-318	glycosylation	2	run 147	UM_A_2011_0318_a3-FL318.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0318_a3-FL318.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-318	None	cell	None
Sample 50	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-18	glycosylation	2	run 148	UM_A_2011_0353_a1-FL18.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0353_a1-FL18.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-18	None	cell	None
Sample 50	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-18	glycosylation	2	run 149	UM_A_2011_0353_a2-FL18.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0353_a2-FL18.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-18	None	cell	None
Sample 50	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-18	glycosylation	2	run 150	UM_A_2011_0353_a3-FL18.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0353_a3-FL18.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-18	None	cell	None
Sample 51	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-518	glycosylation	1	run 151	UM_A_2011_0354_a1-FL518.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0354_a1-FL518.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-518	None	cell	None
Sample 51	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-518	glycosylation	1	run 152	UM_A_2011_0354_a2-FL518.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0354_a2-FL518.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-518	None	cell	None
Sample 51	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-518	glycosylation	1	run 153	UM_A_2011_0354_a3-FL518.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0354_a3-FL518.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-518	None	cell	None
Sample 52	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-18	glycosylation	3	run 154	UM_A_2011_0509_a1-FL18.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0509_a1-FL18.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-18	None	cell	None
Sample 52	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-18	glycosylation	3	run 155	UM_A_2011_0509_a2-FL18.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0509_a2-FL18.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-18	None	cell	None
Sample 52	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-18	glycosylation	3	run 156	UM_A_2011_0509_a3-FL18.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0509_a3-FL18.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-18	None	cell	None
Sample 53	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-318	glycosylation	3	run 157	UM_A_2011_0510_a1-FL318.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0510_a1-FL318.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-318	None	cell	None
Sample 53	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-318	glycosylation	3	run 158	UM_A_2011_0510_a2-FL318.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0510_a2-FL318.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-318	None	cell	None
Sample 53	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-318	glycosylation	3	run 159	UM_A_2011_0510_a3-FL318.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0510_a3-FL318.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-318	None	cell	None
Sample 54	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-518	glycosylation	2	run 160	UM_A_2011_0511_a1-FL518.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0511_a1-FL518.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-518	None	cell	None
Sample 54	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-518	glycosylation	2	run 161	UM_A_2011_0511_a2-FL518.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0511_a2-FL518.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-518	None	cell	None
Sample 54	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-518	glycosylation	2	run 162	UM_A_2011_0511_a3-FL518.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0511_a3-FL518.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-518	None	cell	None
Sample 55	Homo sapiens	lymph node	not available	not available	Burkitt lymphoma	not available	B lymphocyte	BJA-B	glycosylation	2	run 163	UM_A_2011_0513_a1-BJAB.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0513_a1-BJAB.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	BJA-B	None	cell	None
Sample 55	Homo sapiens	lymph node	not available	not available	Burkitt lymphoma	not available	B lymphocyte	BJA-B	glycosylation	2	run 164	UM_A_2011_0513_a2-BJAB.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0513_a2-BJAB.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	BJA-B	None	cell	None
Sample 55	Homo sapiens	lymph node	not available	not available	Burkitt lymphoma	not available	B lymphocyte	BJA-B	glycosylation	2	run 165	UM_A_2011_0513_a3-BJAB.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0513_a3-BJAB.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	BJA-B	None	cell	None
Sample 56	Homo sapiens	lymph node	not available	not available	Burkitt lymphoma	not available	B lymphocyte	FL-518	glycosylation	3	run 166	UM_A_2011_0714_a1-FL518.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0714_a1-FL518.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-518	None	cell	None
Sample 56	Homo sapiens	lymph node	not available	not available	Burkitt lymphoma	not available	B lymphocyte	FL-518	glycosylation	3	run 167	UM_A_2011_0714_a2-FL518.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0714_a2-FL518.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-518	None	cell	None
Sample 56	Homo sapiens	lymph node	not available	not available	Burkitt lymphoma	not available	B lymphocyte	FL-518	glycosylation	3	run 168	UM_A_2011_0714_a3-FL518.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0714_a3-FL518.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-518	None	cell	None
Sample 57	Homo sapiens	lymph node	44Y	male	Transformed follicular lymphoma	not available	B lymphocyte	OCI-Ly1	glycosylation	1	run 169	UM_A_2011_0912_a1-OCILY1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0912_a1-OCILY1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly1	None	cell	None
Sample 57	Homo sapiens	lymph node	44Y	male	Transformed follicular lymphoma	not available	B lymphocyte	OCI-Ly1	glycosylation	1	run 170	UM_A_2011_0912_a2-OCILY1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0912_a2-OCILY1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly1	None	cell	None
Sample 57	Homo sapiens	lymph node	44Y	male	Transformed follicular lymphoma	not available	B lymphocyte	OCI-Ly1	glycosylation	1	run 171	UM_A_2011_0912_a3-OCILY1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0912_a3-OCILY1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly1	None	cell	None
Sample 58	Homo sapiens	lymph node	57Y	male	Mantle cell lymphoma	not available	lymphoblast	Rec-1	glycosylation	1	run 172	UM_A_2011_0913_a1-REC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0913_a1-REC1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Rec-1	None	cell	None
Sample 58	Homo sapiens	lymph node	57Y	male	Mantle cell lymphoma	not available	lymphoblast	Rec-1	glycosylation	1	run 173	UM_A_2011_0913_a2-REC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0913_a2-REC1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Rec-1	None	cell	None
Sample 58	Homo sapiens	lymph node	57Y	male	Mantle cell lymphoma	not available	lymphoblast	Rec-1	glycosylation	1	run 174	UM_A_2011_0913_a3-REC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0913_a3-REC1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Rec-1	None	cell	None
Sample 59	Homo sapiens	lymph node	44Y	male	Transformed follicular lymphoma	not available	B lymphocyte	OCI-Ly1	glycosylation	2	run 175	UM_A_2011_0932_a1-OCILY1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0932_a1-OCILY1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly1	None	cell	None
Sample 59	Homo sapiens	lymph node	44Y	male	Transformed follicular lymphoma	not available	B lymphocyte	OCI-Ly1	glycosylation	2	run 176	UM_A_2011_0932_a2-OCILY1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0932_a2-OCILY1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly1	None	cell	None
Sample 59	Homo sapiens	lymph node	44Y	male	Transformed follicular lymphoma	not available	B lymphocyte	OCI-Ly1	glycosylation	2	run 177	UM_A_2011_0932_a3-OCILY1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0932_a3-OCILY1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly1	None	cell	None
Sample 60	Homo sapiens	lymph node	57Y	male	Mantle cell lymphoma	not available	lymphoblast	Rec-1	glycosylation	2	run 178	UM_A_2011_0933_a1-REC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0933_a1-REC1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Rec-1	None	cell	None
Sample 60	Homo sapiens	lymph node	57Y	male	Mantle cell lymphoma	not available	lymphoblast	Rec-1	glycosylation	2	run 179	UM_A_2011_0933_a2-REC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0933_a2-REC1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Rec-1	None	cell	None
Sample 60	Homo sapiens	lymph node	57Y	male	Mantle cell lymphoma	not available	lymphoblast	Rec-1	glycosylation	2	run 180	UM_A_2011_0933_a3-REC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0933_a3-REC1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Rec-1	None	cell	None
Sample 61	Homo sapiens	lymph node	57Y	male	Mantle cell lymphoma	not available	lymphoblast	Rec-1	glycosylation	3	run 181	UM_A_2011_0935_a1-REC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0935_a1-REC1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Rec-1	None	cell	None
Sample 61	Homo sapiens	lymph node	57Y	male	Mantle cell lymphoma	not available	lymphoblast	Rec-1	glycosylation	3	run 182	UM_A_2011_0935_a2-REC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0935_a2-REC1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Rec-1	None	cell	None
Sample 61	Homo sapiens	lymph node	57Y	male	Mantle cell lymphoma	not available	lymphoblast	Rec-1	glycosylation	3	run 183	UM_A_2011_0935_a3-REC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0935_a3-REC1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Rec-1	None	cell	None
Sample 62	Homo sapiens	lymph node	44Y	male	Transformed follicular lymphoma	not available	B lymphocyte	OCI-Ly1	glycosylation	3	run 184	UM_A_2011_0936_a1-OCILY1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0936_a1-OCILY1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly1	None	cell	None
Sample 62	Homo sapiens	lymph node	44Y	male	Transformed follicular lymphoma	not available	B lymphocyte	OCI-Ly1	glycosylation	3	run 185	UM_A_2011_0936_a2-OCILY1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0936_a2-OCILY1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly1	None	cell	None
Sample 62	Homo sapiens	lymph node	44Y	male	Transformed follicular lymphoma	not available	B lymphocyte	OCI-Ly1	glycosylation	3	run 186	UM_A_2011_0936_a3-OCILY1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0936_a3-OCILY1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly1	None	cell	None
Sample 63	Homo sapiens	lymph node	not available	not available	Burkitt lymphoma	not available	B lymphocyte	BJA-B	glycosylation	3	run 187	UM_A_2011_1051_a1-BJAB.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_1051_a1-BJAB.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	BJA-B	None	cell	None
Sample 63	Homo sapiens	lymph node	not available	not available	Burkitt lymphoma	not available	B lymphocyte	BJA-B	glycosylation	3	run 188	UM_A_2011_1051_a2-BJAB.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_1051_a2-BJAB.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	BJA-B	None	cell	None
Sample 63	Homo sapiens	lymph node	not available	not available	Burkitt lymphoma	not available	B lymphocyte	BJA-B	glycosylation	3	run 189	UM_A_2011_1051_a3-BJAB.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_1051_a3-BJAB.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	BJA-B	None	cell	None
Sample 64	Homo sapiens	peripheral blood	61Y	male	cutaneous T cell lymphoma	Caucasian	T lymphocyte	HH	glycosylation	1	run 190	UM_A_2011_1311_a1-HH.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_1311_a1-HH.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	HH	None	cell	None
Sample 64	Homo sapiens	peripheral blood	61Y	male	cutaneous T cell lymphoma	Caucasian	T lymphocyte	HH	glycosylation	1	run 191	UM_A_2011_1311_a2-HH.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_1311_a2-HH.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	HH	None	cell	None
Sample 64	Homo sapiens	peripheral blood	61Y	male	cutaneous T cell lymphoma	Caucasian	T lymphocyte	HH	glycosylation	1	run 192	UM_A_2011_1311_a3-HH.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_1311_a3-HH.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	HH	None	cell	None
Sample 65	Homo sapiens	peripheral blood	61Y	male	cutaneous T cell lymphoma	Caucasian	T lymphocyte	HH	glycosylation	2	run 193	UM_A_2011_1312_a1-HH.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_1312_a1-HH.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	HH	None	cell	None
Sample 65	Homo sapiens	peripheral blood	61Y	male	cutaneous T cell lymphoma	Caucasian	T lymphocyte	HH	glycosylation	2	run 194	UM_A_2011_1312_a2-HH.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_1312_a2-HH.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	HH	None	cell	None
Sample 65	Homo sapiens	peripheral blood	61Y	male	cutaneous T cell lymphoma	Caucasian	T lymphocyte	HH	glycosylation	2	run 195	UM_A_2011_1312_a3-HH.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_1312_a3-HH.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	HH	None	cell	None
Sample 66	Homo sapiens	peripheral blood	61Y	male	cutaneous T cell lymphoma	Caucasian	T lymphocyte	HH	glycosylation	3	run 196	UM_A_2012_0175_a1-HH.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0175_a1-HH.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	HH	None	cell	None
Sample 66	Homo sapiens	peripheral blood	61Y	male	cutaneous T cell lymphoma	Caucasian	T lymphocyte	HH	glycosylation	3	run 197	UM_A_2012_0175_a2-HH.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0175_a2-HH.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	HH	None	cell	None
Sample 66	Homo sapiens	peripheral blood	61Y	male	cutaneous T cell lymphoma	Caucasian	T lymphocyte	HH	glycosylation	3	run 198	UM_A_2012_0175_a3-HH.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0175_a3-HH.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	HH	None	cell	None
Sample 67	Homo sapiens	T lymphocyte	53Y	male	Sezary Syndrome	Caucasian	cutaneous T lymphocyte	Hut-78	glycosylation	1	run 199	UM_A_2012_0218_a1-HUT78.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0218_a1-HUT78.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Hut-78	None	cell	None
Sample 67	Homo sapiens	T lymphocyte	53Y	male	Sezary Syndrome	Caucasian	cutaneous T lymphocyte	Hut-78	glycosylation	1	run 200	UM_A_2012_0218_a2-HUT78.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0218_a2-HUT78.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Hut-78	None	cell	None
Sample 67	Homo sapiens	T lymphocyte	53Y	male	Sezary Syndrome	Caucasian	cutaneous T lymphocyte	Hut-78	glycosylation	1	run 201	UM_A_2012_0218_a3-HUT78.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0218_a3-HUT78.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Hut-78	None	cell	None
Sample 68	Homo sapiens	T lymphocyte	53Y	male	Sezary Syndrome	Caucasian	cutaneous T lymphocyte	Hut-78	glycosylation	2	run 202	UM_A_2012_0471_a1-HUT78.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0471_a1-HUT78.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Hut-78	None	cell	None
Sample 68	Homo sapiens	T lymphocyte	53Y	male	Sezary Syndrome	Caucasian	cutaneous T lymphocyte	Hut-78	glycosylation	2	run 203	UM_A_2012_0471_a2-HUT78.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0471_a2-HUT78.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Hut-78	None	cell	None
Sample 68	Homo sapiens	T lymphocyte	53Y	male	Sezary Syndrome	Caucasian	cutaneous T lymphocyte	Hut-78	glycosylation	2	run 204	UM_A_2012_0471_a3-HUT78.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0471_a3-HUT78.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Hut-78	None	cell	None
Sample 69	Homo sapiens	Lymphoma	not available	not available	"Anaplastic large cell lymphoma,"	not available	T lymphocyte	Karpas 299	glycosylation	1	run 205	UM_A_2012_0581_a1-KARPAS299.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0581_a1-KARPAS299.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	None	cell	None
Sample 69	Homo sapiens	Lymphoma	not available	not available	"Anaplastic large cell lymphoma,"	not available	T lymphocyte	Karpas 299	glycosylation	1	run 206	UM_A_2012_0581_a2-KARPAS299.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0581_a2-KARPAS299.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	None	cell	None
Sample 69	Homo sapiens	Lymphoma	not available	not available	"Anaplastic large cell lymphoma,"	not available	T lymphocyte	Karpas 299	glycosylation	1	run 207	UM_A_2012_0581_a3-KARPAS299.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0581_a3-KARPAS299.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	None	cell	None
Sample 70	Homo sapiens	Lymphoma	not available	not available	"Anaplastic large cell lymphoma,"	not available	T lymphocyte	Karpas 299	glycosylation	2	run 208	UM_A_2012_0582_a1-KARPAS299.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0582_a1-KARPAS299.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	None	cell	None
Sample 70	Homo sapiens	Lymphoma	not available	not available	"Anaplastic large cell lymphoma,"	not available	T lymphocyte	Karpas 299	glycosylation	2	run 209	UM_A_2012_0582_a2-KARPAS299.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0582_a2-KARPAS299.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	None	cell	None
Sample 70	Homo sapiens	Lymphoma	not available	not available	"Anaplastic large cell lymphoma,"	not available	T lymphocyte	Karpas 299	glycosylation	2	run 210	UM_A_2012_0582_a3-KARPAS299.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0582_a3-KARPAS299.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	None	cell	None
Sample 71	Homo sapiens	lymph node	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SR-786	glycosylation	1	run 211	UM_A_2012_0675_a1-SR786.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0675_a1-SR786.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SR-786	None	cell	None
Sample 71	Homo sapiens	lymph node	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SR-786	glycosylation	1	run 212	UM_A_2012_0675_a2-SR786.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0675_a2-SR786.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SR-786	None	cell	None
Sample 71	Homo sapiens	lymph node	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SR-786	glycosylation	1	run 213	UM_A_2012_0675_a3-SR786.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0675_a3-SR786.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SR-786	None	cell	None
Sample 72	Homo sapiens	lymph node	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SR-786	glycosylation	2	run 214	UM_A_2012_0677_a1-SR786.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0677_a1-SR786.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SR-786	None	cell	None
Sample 72	Homo sapiens	lymph node	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SR-786	glycosylation	2	run 215	UM_A_2012_0677_a2-SR786.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0677_a2-SR786.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SR-786	None	cell	None
Sample 72	Homo sapiens	lymph node	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SR-786	glycosylation	2	run 216	UM_A_2012_0677_a3-SR786.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0677_a3-SR786.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SR-786	None	cell	None
Sample 73	Homo sapiens	Lymphoma	not available	not available	"Anaplastic large cell lymphoma,"	not available	T lymphocyte	Karpas 299	glycosylation	3	run 217	UM_A_2012_0715_a1-KARPAS299.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0715_a1-KARPAS299.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	None	cell	None
Sample 73	Homo sapiens	Lymphoma	not available	not available	"Anaplastic large cell lymphoma,"	not available	T lymphocyte	Karpas 299	glycosylation	3	run 218	UM_A_2012_0715_a2-KARPAS299.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0715_a2-KARPAS299.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	None	cell	None
Sample 73	Homo sapiens	Lymphoma	not available	not available	"Anaplastic large cell lymphoma,"	not available	T lymphocyte	Karpas 299	glycosylation	3	run 219	UM_A_2012_0715_a3-KARPAS299.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0715_a3-KARPAS299.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	None	cell	None
Sample 74	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SUP-M2	glycosylation	1	run 220	UM_A_2012_0738_a1-SUPM2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0738_a1-SUPM2.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUP-M2	None	cell	None
Sample 74	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SUP-M2	glycosylation	1	run 221	UM_A_2012_0738_a2-SUPM2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0738_a2-SUPM2.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUP-M2	None	cell	None
Sample 74	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SUP-M2	glycosylation	1	run 222	UM_A_2012_0738_a3-SUPM2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0738_a3-SUPM2.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUP-M2	None	cell	None
Sample 75	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SUP-M2	glycosylation	2	run 223	UM_A_2012_0739_a1-SUPM2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0739_a1-SUPM2.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUP-M2	None	cell	None
Sample 75	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SUP-M2	glycosylation	2	run 224	UM_A_2012_0739_a2-SUPM2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0739_a2-SUPM2.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUP-M2	None	cell	None
Sample 75	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SUP-M2	glycosylation	2	run 225	UM_A_2012_0739_a3-SUPM2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0739_a3-SUPM2.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUP-M2	None	cell	None
Sample 76	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SUP-M2	glycosylation	3	run 226	UM_A_2012_0740_a1-SUPM2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0740_a1-SUPM2.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUP-M2	None	cell	None
Sample 76	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SUP-M2	glycosylation	3	run 227	UM_A_2012_0740_a2-SUPM2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0740_a2-SUPM2.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUP-M2	None	cell	None
Sample 76	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SUP-M2	glycosylation	3	run 228	UM_A_2012_0740_a3-SUPM2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0740_a3-SUPM2.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUP-M2	None	cell	None
Sample 77	Homo sapiens	lymphoblastic	15Y	male	Aggressive NK-cell leukemia	not available	lymphoblastic	YT	glycosylation	1	run 229	UM_A_2012_0770_a1-YT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0770_a1-YT.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	YT	None	cell	None
Sample 77	Homo sapiens	lymphoblastic	15Y	male	Aggressive NK-cell leukemia	not available	lymphoblastic	YT	glycosylation	1	run 230	UM_A_2012_0770_a2-YT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0770_a2-YT.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	YT	None	cell	None
Sample 77	Homo sapiens	lymphoblastic	15Y	male	Aggressive NK-cell leukemia	not available	lymphoblastic	YT	glycosylation	1	run 231	UM_A_2012_0770_a3-YT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0770_a3-YT.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	YT	None	cell	None
Sample 78	Homo sapiens	lymphoblastic	15Y	male	Aggressive NK-cell leukemia	not available	lymphoblastic	YT	glycosylation	2	run 232	UM_A_2012_0771_a1-YT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0771_a1-YT.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	YT	None	cell	None
Sample 78	Homo sapiens	lymphoblastic	15Y	male	Aggressive NK-cell leukemia	not available	lymphoblastic	YT	glycosylation	2	run 233	UM_A_2012_0771_a2-YT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0771_a2-YT.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	YT	None	cell	None
Sample 78	Homo sapiens	lymphoblastic	15Y	male	Aggressive NK-cell leukemia	not available	lymphoblastic	YT	glycosylation	2	run 234	UM_A_2012_0771_a3-YT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0771_a3-YT.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	YT	None	cell	None
Sample 79	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-1	glycosylation	1	run 235	UM_A_2012_0772_a1-MAC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0772_a1-MAC1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-1	None	cell	None
Sample 79	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-1	glycosylation	1	run 236	UM_A_2012_0772_a2-MAC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0772_a2-MAC1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-1	None	cell	None
Sample 79	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-1	glycosylation	1	run 237	UM_A_2012_0772_a3-MAC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0772_a3-MAC1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-1	None	cell	None
Sample 80	Homo sapiens	lymph node	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SR-786	glycosylation	3	run 238	UM_A_2012_0816_a1-SR786.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0816_a1-SR786.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SR-786	None	cell	None
Sample 80	Homo sapiens	lymph node	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SR-786	glycosylation	3	run 239	UM_A_2012_0816_a2-SR786.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0816_a2-SR786.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SR-786	None	cell	None
Sample 80	Homo sapiens	lymph node	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SR-786	glycosylation	3	run 240	UM_A_2012_0816_a3-SR786.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0816_a3-SR786.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SR-786	None	cell	None
Sample 81	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-1	glycosylation	2	run 241	UM_A_2012_0818_a1-MAC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0818_a1-MAC1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-1	None	cell	None
Sample 81	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-1	glycosylation	2	run 242	UM_A_2012_0818_a2-MAC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0818_a2-MAC1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-1	None	cell	None
Sample 81	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-1	glycosylation	2	run 243	UM_A_2012_0818_a3-MAC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0818_a3-MAC1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-1	None	cell	None
Sample 82	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia		T lymphocyte	Jurkat	glycosylation	1	run 244	UM_A_2012_0863_a1-JURKAT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0863_a1-JURKAT.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	None	cell	None
Sample 82	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia		T lymphocyte	Jurkat	glycosylation	1	run 245	UM_A_2012_0863_a2-JURKAT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0863_a2-JURKAT.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	None	cell	None
Sample 82	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia		T lymphocyte	Jurkat	glycosylation	1	run 246	UM_A_2012_0863_a3-JURKAT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0863_a3-JURKAT.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	None	cell	None
Sample 83	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia		T lymphocyte	Jurkat	glycosylation	2	run 247	UM_A_2012_0864_a1-JURKAT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0864_a1-JURKAT.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	None	cell	None
Sample 83	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia		T lymphocyte	Jurkat	glycosylation	2	run 248	UM_A_2012_0864_a2-JURKAT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0864_a2-JURKAT.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	None	cell	None
Sample 83	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia		T lymphocyte	Jurkat	glycosylation	2	run 249	UM_A_2012_0864_a3-JURKAT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0864_a3-JURKAT.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	None	cell	None
Sample 84	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia		T lymphocyte	Jurkat	glycosylation	3	run 250	UM_A_2012_0866_a1-JURKAT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0866_a1-JURKAT.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	None	cell	None
Sample 84	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia		T lymphocyte	Jurkat	glycosylation	3	run 251	UM_A_2012_0866_a2-JURKAT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0866_a2-JURKAT.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	None	cell	None
Sample 84	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia		T lymphocyte	Jurkat	glycosylation	3	run 252	UM_A_2012_0866_a3-JURKAT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0866_a3-JURKAT.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	None	cell	None
Sample 85	Homo sapiens	peripheral blood	75Y	female	Mantle cell lymphoma	not applicable	not applicable	not applicable	glycosylation	1	run 253	UM_A_2012_0916_a1-PATEINT_3.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0916_a1-PATEINT_3.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	cell	None
Sample 85	Homo sapiens	peripheral blood	75Y	female	Mantle cell lymphoma	not applicable	not applicable	not applicable	glycosylation	1	run 254	UM_A_2012_0916_a2-PATEINT_3.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0916_a2-PATEINT_3.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	cell	None
Sample 85	Homo sapiens	peripheral blood	75Y	female	Mantle cell lymphoma	not applicable	not applicable	not applicable	glycosylation	1	run 255	UM_A_2012_0916_a3-PATEINT_3.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0916_a3-PATEINT_3.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	cell	None
Sample 86	Homo sapiens	peripheral blood	79Y	female	follicular lymphoma	not applicable	not applicable	not applicable	glycosylation	1	run 256	UM_A_2012_0917_a1-PATEINT_6.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0917_a1-PATEINT_6.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	cell	None
Sample 86	Homo sapiens	peripheral blood	79Y	female	follicular lymphoma	not applicable	not applicable	not applicable	glycosylation	1	run 257	UM_A_2012_0917_a2-PATEINT_6.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0917_a2-PATEINT_6.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	cell	None
Sample 86	Homo sapiens	peripheral blood	79Y	female	follicular lymphoma	not applicable	not applicable	not applicable	glycosylation	1	run 258	UM_A_2012_0917_a3-PATEINT_6.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0917_a3-PATEINT_6.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	cell	None
Sample 87	Homo sapiens	peripheral blood	67Y	male	Mantle cell lymphoma	not applicable	not applicable	not applicable	glycosylation	1	run 259	UM_A_2012_0960_a1-PATEINT_1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0960_a1-PATEINT_1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	cell	None
Sample 87	Homo sapiens	peripheral blood	67Y	male	Mantle cell lymphoma	not applicable	not applicable	not applicable	glycosylation	1	run 260	UM_A_2012_0960_a2-PATEINT_1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0960_a2-PATEINT_1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	cell	None
Sample 87	Homo sapiens	peripheral blood	67Y	male	Mantle cell lymphoma	not applicable	not applicable	not applicable	glycosylation	1	run 261	UM_A_2012_0960_a3-PATEINT_1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0960_a3-PATEINT_1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	cell	None
Sample 88	Homo sapiens	peripheral blood	68Y	male	Mantle cell lymphoma	not applicable	not applicable	not applicable	glycosylation	1	run 262	UM_A_2012_0961_a1-PATEINT_2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0961_a1-PATEINT_2.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	cell	None
Sample 88	Homo sapiens	peripheral blood	68Y	male	Mantle cell lymphoma	not applicable	not applicable	not applicable	glycosylation	1	run 263	UM_A_2012_0961_a2-PATEINT_2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0961_a2-PATEINT_2.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	cell	None
Sample 88	Homo sapiens	peripheral blood	68Y	male	Mantle cell lymphoma	not applicable	not applicable	not applicable	glycosylation	1	run 264	UM_A_2012_0961_a3-PATEINT_2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0961_a3-PATEINT_2.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	cell	None
Sample 89	Homo sapiens	peripheral blood	55Y	female	Mantle cell lymphoma	not applicable	not applicable	not applicable	glycosylation	1	run 265	UM_A_2012_0962_a1-PATEINT_4.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0962_a1-PATEINT_4.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	cell	None
Sample 89	Homo sapiens	peripheral blood	55Y	female	Mantle cell lymphoma	not applicable	not applicable	not applicable	glycosylation	1	run 266	UM_A_2012_0962_a2-PATEINT_4.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0962_a2-PATEINT_4.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	cell	None
Sample 89	Homo sapiens	peripheral blood	55Y	female	Mantle cell lymphoma	not applicable	not applicable	not applicable	glycosylation	1	run 267	UM_A_2012_0962_a3-PATEINT_4.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0962_a3-PATEINT_4.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	cell	None
Sample 90	Homo sapiens	peripheral blood	62Y	female	follicular lymphoma	not applicable	not applicable	not applicable	glycosylation	1	run 268	UM_A_2012_0963_a1-PATEINT_5.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0963_a1-PATEINT_5.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	cell	None
Sample 90	Homo sapiens	peripheral blood	62Y	female	follicular lymphoma	not applicable	not applicable	not applicable	glycosylation	1	run 269	UM_A_2012_0963_a2-PATEINT_5.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0963_a2-PATEINT_5.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	cell	None
Sample 90	Homo sapiens	peripheral blood	62Y	female	follicular lymphoma	not applicable	not applicable	not applicable	glycosylation	1	run 270	UM_A_2012_0963_a3-PATEINT_5.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0963_a3-PATEINT_5.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	cell	None
Sample 91	Homo sapiens	peripheral blood	63Y	female	follicular lymphoma	not applicable	not applicable	not applicable	glycosylation	1	run 271	UM_A_2012_0964_a1-PATEINT_7.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0964_a1-PATEINT_7.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	cell	None
Sample 91	Homo sapiens	peripheral blood	63Y	female	follicular lymphoma	not applicable	not applicable	not applicable	glycosylation	1	run 272	UM_A_2012_0964_a2-PATEINT_7.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0964_a2-PATEINT_7.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	cell	None
Sample 91	Homo sapiens	peripheral blood	63Y	female	follicular lymphoma	not applicable	not applicable	not applicable	glycosylation	1	run 273	UM_A_2012_0964_a3-PATEINT_7.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0964_a3-PATEINT_7.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	cell	None
Sample 92	Homo sapiens	peripheral blood	51Y	female	follicular lymphoma	not applicable	not applicable	not applicable	glycosylation	1	run 274	UM_A_2012_0965_a1-PATEINT_8.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0965_a1-PATEINT_8.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	cell	None
Sample 92	Homo sapiens	peripheral blood	51Y	female	follicular lymphoma	not applicable	not applicable	not applicable	glycosylation	1	run 275	UM_A_2012_0965_a2-PATEINT_8.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0965_a2-PATEINT_8.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	cell	None
Sample 92	Homo sapiens	peripheral blood	51Y	female	follicular lymphoma	not applicable	not applicable	not applicable	glycosylation	1	run 276	UM_A_2012_0965_a3-PATEINT_8.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0965_a3-PATEINT_8.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	cell	None
Sample 93	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-2A	glycosylation	1	run 277	UM_A_2012_0974_a1-MAC2A.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0974_a1-MAC2A.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-2A	None	cell	None
Sample 93	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-2A	glycosylation	1	run 278	UM_A_2012_0974_a2-MAC2A.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0974_a2-MAC2A.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-2A	None	cell	None
Sample 93	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-2A	glycosylation	1	run 279	UM_A_2012_0974_a3-MAC2A.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0974_a3-MAC2A.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-2A	None	cell	None
Sample 94	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-2A	glycosylation	2	run 280	UM_A_2012_0975_a1-MAC2A.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0975_a1-MAC2A.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-2A	None	cell	None
Sample 94	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-2A	glycosylation	2	run 281	UM_A_2012_0975_a2-MAC2A.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0975_a2-MAC2A.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-2A	None	cell	None
Sample 94	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-2A	glycosylation	2	run 282	UM_A_2012_0975_a3-MAC2A.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0975_a3-MAC2A.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-2A	None	cell	None
Sample 95	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-2A	glycosylation	3	run 283	UM_A_2012_0976_a1-MAC2A.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0976_a1-MAC2A.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-2A	None	cell	None
Sample 95	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-2A	glycosylation	3	run 284	UM_A_2012_0976_a2-MAC2A.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0976_a2-MAC2A.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-2A	None	cell	None
Sample 95	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-2A	glycosylation	3	run 285	UM_A_2012_0976_a3-MAC2A.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0976_a3-MAC2A.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-2A	None	cell	None
Sample 96	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-1	glycosylation	3	run 286	UM_A_2012_0977_a1-MAC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0977_a1-MAC1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-1	None	cell	None
Sample 96	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-1	glycosylation	3	run 287	UM_A_2012_0977_a2-MAC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0977_a2-MAC1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-1	None	cell	None
Sample 96	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-1	glycosylation	3	run 288	UM_A_2012_0977_a3-MAC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0977_a3-MAC1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-1	None	cell	None
Sample 97	Homo sapiens	T lymphocyte	53Y	male	Sezary Syndrome	Caucasian	cutaneous T lymphocyte	Hut-78	glycosylation	3	run 289	UM_A_2012_0978_a1-HUT78.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0978_a1-HUT78.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Hut-78	None	cell	None
Sample 97	Homo sapiens	T lymphocyte	53Y	male	Sezary Syndrome	Caucasian	cutaneous T lymphocyte	Hut-78	glycosylation	3	run 290	UM_A_2012_0978_a2-HUT78.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0978_a2-HUT78.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Hut-78	None	cell	None
Sample 97	Homo sapiens	T lymphocyte	53Y	male	Sezary Syndrome	Caucasian	cutaneous T lymphocyte	Hut-78	glycosylation	3	run 291	UM_A_2012_0978_a3-HUT78.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0978_a3-HUT78.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Hut-78	None	cell	None
Sample 98	Homo sapiens	lymphoblastic	15Y	male	Aggressive NK-cell leukemia	not available	lymphoblastic	YT	glycosylation	3	run 292	UM_A_2012_0979_a1-YT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0979_a1-YT.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	YT	None	cell	None
Sample 98	Homo sapiens	lymphoblastic	15Y	male	Aggressive NK-cell leukemia	not available	lymphoblastic	YT	glycosylation	3	run 293	UM_A_2012_0979_a2-YT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0979_a2-YT.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	YT	None	cell	None
Sample 98	Homo sapiens	lymphoblastic	15Y	male	Aggressive NK-cell leukemia	not available	lymphoblastic	YT	glycosylation	3	run 294	UM_A_2012_0979_a3-YT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0979_a3-YT.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	YT	None	cell	None
Sample 99	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92MI	glycosylation	1	run 295	UM_A_2012_1009_a1-NK92MI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1009_a1-NK92MI.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92MI	None	cell	None
Sample 99	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92MI	glycosylation	1	run 296	UM_A_2012_1009_a2-NK92MI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1009_a2-NK92MI.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92MI	None	cell	None
Sample 99	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92MI	glycosylation	1	run 297	UM_A_2012_1009_a3-NK92MI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1009_a3-NK92MI.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92MI	None	cell	None
Sample 100	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92MI	glycosylation	2	run 298	UM_A_2012_1010_a1-NK92MI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1010_a1-NK92MI.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92MI	None	cell	None
Sample 100	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92MI	glycosylation	2	run 299	UM_A_2012_1010_a2-NK92MI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1010_a2-NK92MI.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92MI	None	cell	None
Sample 100	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92MI	glycosylation	2	run 300	UM_A_2012_1010_a3-NK92MI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1010_a3-NK92MI.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92MI	None	cell	None
Sample 101	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92MI	glycosylation	3	run 301	UM_A_2012_1011_a1-NK92MI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1011_a1-NK92MI.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92MI	None	cell	None
Sample 101	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92MI	glycosylation	3	run 302	UM_A_2012_1011_a2-NK92MI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1011_a2-NK92MI.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92MI	None	cell	None
Sample 101	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92MI	glycosylation	3	run 303	UM_A_2012_1011_a3-NK92MI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1011_a3-NK92MI.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92MI	None	cell	None
Sample 102	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92	glycosylation	1	run 304	UM_A_2012_1459_a1-NK92.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1459_a1-NK92.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92	None	cell	None
Sample 102	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92	glycosylation	1	run 305	UM_A_2012_1459_a2-NK92.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1459_a2-NK92.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92	None	cell	None
Sample 102	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92	glycosylation	1	run 306	UM_A_2012_1459_a3-NK92.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1459_a3-NK92.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92	None	cell	None
Sample 103	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92	glycosylation	2	run 307	UM_A_2012_1460_a1-NK92.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1460_a1-NK92.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92	None	cell	None
Sample 103	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92	glycosylation	2	run 308	UM_A_2012_1460_a2-NK92.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1460_a2-NK92.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92	None	cell	None
Sample 103	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92	glycosylation	2	run 309	UM_A_2012_1460_a3-NK92.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1460_a3-NK92.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92	None	cell	None
Sample 104	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92	glycosylation	3	run 310	UM_A_2012_1461_a1-NK92.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1461_a1-NK92.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92	None	cell	None
Sample 104	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92	glycosylation	3	run 311	UM_A_2012_1461_a2-NK92.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1461_a2-NK92.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92	None	cell	None
Sample 104	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92	glycosylation	3	run 312	UM_A_2012_1461_a3-NK92.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1461_a3-NK92.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92	None	cell	None
Sample 105	Homo sapiens	Lymphoma	not available	not available	"Anaplastic large cell lymphoma,"	not available	T lymphocyte	Karpas 299	glycosylation	1	run 313	UM_A_2013_0202_a1-KARPAS299_DMSO_1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0202_a1-KARPAS299_DMSO_1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	DMSO	cell	DMSO
Sample 105	Homo sapiens	Lymphoma	not available	not available	"Anaplastic large cell lymphoma,"	not available	T lymphocyte	Karpas 299	glycosylation	1	run 314	UM_A_2013_0202_a2-KARPAS299_DMSO_1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0202_a2-KARPAS299_DMSO_1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	DMSO	cell	DMSO
Sample 105	Homo sapiens	Lymphoma	not available	not available	"Anaplastic large cell lymphoma,"	not available	T lymphocyte	Karpas 299	glycosylation	1	run 315	UM_A_2013_0202_a3-KARPAS299_DMSO_1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0202_a3-KARPAS299_DMSO_1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	DMSO	cell	DMSO
Sample 106	Homo sapiens	Lymphoma	not available	not available	"Anaplastic large cell lymphoma,"	not available	T lymphocyte	Karpas 299	glycosylation	1	run 316	UM_A_2013_0203_a1-KARPAS299_ALKI_1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0203_a1-KARPAS299_ALKI_1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	ALK inhibitor	cell	ALK inhibitor
Sample 106	Homo sapiens	Lymphoma	not available	not available	"Anaplastic large cell lymphoma,"	not available	T lymphocyte	Karpas 299	glycosylation	1	run 317	UM_A_2013_0203_a2-KARPAS299_ALKI_1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0203_a2-KARPAS299_ALKI_1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	ALK inhibitor	cell	ALK inhibitor
Sample 106	Homo sapiens	Lymphoma	not available	not available	"Anaplastic large cell lymphoma,"	not available	T lymphocyte	Karpas 299	glycosylation	1	run 318	UM_A_2013_0203_a3-KARPAS299_ALKI_1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0203_a3-KARPAS299_ALKI_1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	ALK inhibitor	cell	ALK inhibitor
Sample 107	Homo sapiens	Lymphoma	not available	not available	"Anaplastic large cell lymphoma,"	not available	T lymphocyte	Karpas 299	glycosylation	2	run 319	UM_A_2013_0204_a1-KARPAS299_DMSO_2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0204_a1-KARPAS299_DMSO_2.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	DMSO	cell	DMSO
Sample 107	Homo sapiens	Lymphoma	not available	not available	"Anaplastic large cell lymphoma,"	not available	T lymphocyte	Karpas 299	glycosylation	2	run 320	UM_A_2013_0204_a2-KARPAS299_DMSO_2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0204_a2-KARPAS299_DMSO_2.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	DMSO	cell	DMSO
Sample 107	Homo sapiens	Lymphoma	not available	not available	"Anaplastic large cell lymphoma,"	not available	T lymphocyte	Karpas 299	glycosylation	2	run 321	UM_A_2013_0204_a3-KARPAS299_DMSO_2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0204_a3-KARPAS299_DMSO_2.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	DMSO	cell	DMSO
Sample 108	Homo sapiens	Lymphoma	not available	not available	"Anaplastic large cell lymphoma,"	not available	T lymphocyte	Karpas 299	glycosylation	2	run 322	UM_A_2013_0205_a1-KARPAS299_ALKI_2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0205_a1-KARPAS299_ALKI_2.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	ALK inhibitor	cell	ALK inhibitor
Sample 108	Homo sapiens	Lymphoma	not available	not available	"Anaplastic large cell lymphoma,"	not available	T lymphocyte	Karpas 299	glycosylation	2	run 323	UM_A_2013_0205_a2-KARPAS299_ALKI_2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0205_a2-KARPAS299_ALKI_2.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	ALK inhibitor	cell	ALK inhibitor
Sample 108	Homo sapiens	Lymphoma	not available	not available	"Anaplastic large cell lymphoma,"	not available	T lymphocyte	Karpas 299	glycosylation	2	run 324	UM_A_2013_0205_a3-KARPAS299_ALKI_2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0205_a3-KARPAS299_ALKI_2.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	ALK inhibitor	cell	ALK inhibitor
Sample 109	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	1	run 325	UM_A_2013_0206_a1-SUDHL1_DMSO_1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0206_a1-SUDHL1_DMSO_1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	DMSO	cell	DMSO
Sample 109	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	1	run 326	UM_A_2013_0206_a2-SUDHL1_DMSO_1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0206_a2-SUDHL1_DMSO_1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	DMSO	cell	DMSO
Sample 109	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	1	run 327	UM_A_2013_0206_a3-SUDHL1_DMSO_1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0206_a3-SUDHL1_DMSO_1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	DMSO	cell	DMSO
Sample 110	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	1	run 328	UM_A_2013_0207_a1-SUDHL1_ALKI_1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0207_a1-SUDHL1_ALKI_1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	ALK inhibitor	cell	ALK inhibitor
Sample 110	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	1	run 329	UM_A_2013_0207_a2-SUDHL1_ALKI_1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0207_a2-SUDHL1_ALKI_1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	ALK inhibitor	cell	ALK inhibitor
Sample 110	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	1	run 330	UM_A_2013_0207_a3-SUDHL1_ALKI_1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0207_a3-SUDHL1_ALKI_1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	ALK inhibitor	cell	ALK inhibitor
Sample 111	Homo sapiens	peripheral blood	61Y	male	plasmacytoma	not available	B lymphocyte	RPMI 8226	glycosylation	1	run 331	UM_A_2013_0230_a1-RPMI8226.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0230_a1-RPMI8226.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	RPMI 8226	None	cell	None
Sample 111	Homo sapiens	peripheral blood	61Y	male	plasmacytoma	not available	B lymphocyte	RPMI 8226	glycosylation	1	run 332	UM_A_2013_0230_a2-RPMI8226.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0230_a2-RPMI8226.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	RPMI 8226	None	cell	None
Sample 111	Homo sapiens	peripheral blood	61Y	male	plasmacytoma	not available	B lymphocyte	RPMI 8226	glycosylation	1	run 333	UM_A_2013_0230_a3-RPMI8226.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0230_a3-RPMI8226.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	RPMI 8226	None	cell	None
Sample 112	Homo sapiens	peripheral blood	not available	female	Multiple Myeloma	not available	B lymphocyte	KMS-11	glycosylation	1	run 334	UM_A_2013_0231_a1-KMS11.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0231_a1-KMS11.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-11	None	cell	None
Sample 112	Homo sapiens	peripheral blood	not available	female	Multiple Myeloma	not available	B lymphocyte	KMS-11	glycosylation	1	run 335	UM_A_2013_0231_a2-KMS11.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0231_a2-KMS11.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-11	None	cell	None
Sample 112	Homo sapiens	peripheral blood	not available	female	Multiple Myeloma	not available	B lymphocyte	KMS-11	glycosylation	1	run 336	UM_A_2013_0231_a3-KMS11.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0231_a3-KMS11.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-11	None	cell	None
Sample 113	Homo sapiens	Lymphoma	not available	not available	"Anaplastic large cell lymphoma,"	not available	T lymphocyte	Karpas 299	glycosylation	3	run 337	UM_A_2013_0232_a1-KARPAS299_DMSO_3.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0232_a1-KARPAS299_DMSO_3.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	DMSO	cell	DMSO
Sample 113	Homo sapiens	Lymphoma	not available	not available	"Anaplastic large cell lymphoma,"	not available	T lymphocyte	Karpas 299	glycosylation	3	run 338	UM_A_2013_0232_a2-KARPAS299_DMSO_3.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0232_a2-KARPAS299_DMSO_3.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	DMSO	cell	DMSO
Sample 113	Homo sapiens	Lymphoma	not available	not available	"Anaplastic large cell lymphoma,"	not available	T lymphocyte	Karpas 299	glycosylation	3	run 339	UM_A_2013_0232_a3-KARPAS299_DMSO_3.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0232_a3-KARPAS299_DMSO_3.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	DMSO	cell	DMSO
Sample 114	Homo sapiens	Lymphoma	not available	not available	"Anaplastic large cell lymphoma,"	not available	T lymphocyte	Karpas 299	glycosylation	3	run 340	UM_A_2013_0233_a1-KARPAS299_ALKI_3.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0233_a1-KARPAS299_ALKI_3.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	ALK inhibitor	cell	ALK inhibitor
Sample 114	Homo sapiens	Lymphoma	not available	not available	"Anaplastic large cell lymphoma,"	not available	T lymphocyte	Karpas 299	glycosylation	3	run 341	UM_A_2013_0233_a2-KARPAS299_ALKI_3.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0233_a2-KARPAS299_ALKI_3.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	ALK inhibitor	cell	ALK inhibitor
Sample 114	Homo sapiens	Lymphoma	not available	not available	"Anaplastic large cell lymphoma,"	not available	T lymphocyte	Karpas 299	glycosylation	3	run 342	UM_A_2013_0233_a3-KARPAS299_ALKI_3.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0233_a3-KARPAS299_ALKI_3.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	ALK inhibitor	cell	ALK inhibitor
Sample 115	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	2	run 343	UM_A_2013_0234_a1-SUDHL1_DMSO_2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0234_a1-SUDHL1_DMSO_2.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	DMSO	cell	DMSO
Sample 115	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	2	run 344	UM_A_2013_0234_a2-SUDHL1_DMSO_2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0234_a2-SUDHL1_DMSO_2.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	DMSO	cell	DMSO
Sample 115	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	2	run 345	UM_A_2013_0234_a3-SUDHL1_DMSO_2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0234_a3-SUDHL1_DMSO_2.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	DMSO	cell	DMSO
Sample 116	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	2	run 346	UM_A_2013_0235_a1-SUDHL1_ALKI_2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0235_a1-SUDHL1_ALKI_2.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	ALK inhibitor	cell	ALK inhibitor
Sample 116	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	2	run 347	UM_A_2013_0235_a2-SUDHL1_ALKI_2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0235_a2-SUDHL1_ALKI_2.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	ALK inhibitor	cell	ALK inhibitor
Sample 116	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	2	run 348	UM_A_2013_0235_a3-SUDHL1_ALKI_2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0235_a3-SUDHL1_ALKI_2.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	ALK inhibitor	cell	ALK inhibitor
Sample 117	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	3	run 349	UM_A_2013_0236_a1-SUDHL1_DMSO_3.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0236_a1-SUDHL1_DMSO_3.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	DMSO	cell	DMSO
Sample 117	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	3	run 350	UM_A_2013_0236_a2-SUDHL1_DMSO_3.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0236_a2-SUDHL1_DMSO_3.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	DMSO	cell	DMSO
Sample 117	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	3	run 351	UM_A_2013_0236_a3-SUDHL1_DMSO_3.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0236_a3-SUDHL1_DMSO_3.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	DMSO	cell	DMSO
Sample 118	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	3	run 352	UM_A_2013_0237_a1-SUDHL1_ALKI_3.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0237_a1-SUDHL1_ALKI_3.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	ALK inhibitor	cell	ALK inhibitor
Sample 118	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	3	run 353	UM_A_2013_0237_a2-SUDHL1_ALKI_3.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0237_a2-SUDHL1_ALKI_3.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	ALK inhibitor	cell	ALK inhibitor
Sample 118	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	3	run 354	UM_A_2013_0237_a3-SUDHL1_ALKI_3.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0237_a3-SUDHL1_ALKI_3.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	ALK inhibitor	cell	ALK inhibitor
Sample 119	Homo sapiens	peripheral blood	not available	female	Multiple Myeloma	not available	B lymphocyte	KMS-11	glycosylation	2	run 355	UM_A_2013_0246_a1-KMS11.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0246_a1-KMS11.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-11	None	cell	None
Sample 119	Homo sapiens	peripheral blood	not available	female	Multiple Myeloma	not available	B lymphocyte	KMS-11	glycosylation	2	run 356	UM_A_2013_0246_a2-KMS11.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0246_a2-KMS11.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-11	None	cell	None
Sample 119	Homo sapiens	peripheral blood	not available	female	Multiple Myeloma	not available	B lymphocyte	KMS-11	glycosylation	2	run 357	UM_A_2013_0246_a3-KMS11.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0246_a3-KMS11.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-11	None	cell	None
Sample 120	Homo sapiens	peripheral blood	61Y	male	plasmacytoma	not available	B lymphocyte	RPMI 8226	glycosylation	2	run 358	UM_A_2013_0247_a1-RPMI8226.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0247_a1-RPMI8226.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	RPMI 8226	None	cell	None
Sample 120	Homo sapiens	peripheral blood	61Y	male	plasmacytoma	not available	B lymphocyte	RPMI 8226	glycosylation	2	run 359	UM_A_2013_0247_a2-RPMI8226.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0247_a2-RPMI8226.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	RPMI 8226	None	cell	None
Sample 120	Homo sapiens	peripheral blood	61Y	male	plasmacytoma	not available	B lymphocyte	RPMI 8226	glycosylation	2	run 360	UM_A_2013_0247_a3-RPMI8226.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0247_a3-RPMI8226.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	RPMI 8226	None	cell	None
Sample 121	Homo sapiens	peripheral blood	not available	female	Multiple Myeloma	not available	B lymphocyte	KMS-11	glycosylation	3	run 361	UM_A_2013_0250_a1-KMS11.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0250_a1-KMS11.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-11	None	cell	None
Sample 121	Homo sapiens	peripheral blood	not available	female	Multiple Myeloma	not available	B lymphocyte	KMS-11	glycosylation	3	run 362	UM_A_2013_0250_a2-KMS11.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0250_a2-KMS11.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-11	None	cell	None
Sample 121	Homo sapiens	peripheral blood	not available	female	Multiple Myeloma	not available	B lymphocyte	KMS-11	glycosylation	3	run 363	UM_A_2013_0250_a3-KMS11.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0250_a3-KMS11.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-11	None	cell	None
Sample 122	Homo sapiens	peripheral blood	61Y	male	plasmacytoma	not available	B lymphocyte	RPMI 8226	glycosylation	3	run 364	UM_A_2013_0252_a1-RPMI8226.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0252_a1-RPMI8226.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	RPMI 8226	None	cell	None
Sample 122	Homo sapiens	peripheral blood	61Y	male	plasmacytoma	not available	B lymphocyte	RPMI 8226	glycosylation	3	run 365	UM_A_2013_0252_a2-RPMI8226.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0252_a2-RPMI8226.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	RPMI 8226	None	cell	None
Sample 122	Homo sapiens	peripheral blood	61Y	male	plasmacytoma	not available	B lymphocyte	RPMI 8226	glycosylation	3	run 366	UM_A_2013_0252_a3-RPMI8226.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0252_a3-RPMI8226.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	RPMI 8226	None	cell	None
Sample 123	Homo sapiens	peripheral blood	64Y	female	Multiple Myeloma	not available	B lymphocyte	KMS-12	glycosylation	1	run 367	UM_A_2013_0255_a1-KMS12.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0255_a1-KMS12.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-12	None	cell	None
Sample 123	Homo sapiens	peripheral blood	64Y	female	Multiple Myeloma	not available	B lymphocyte	KMS-12	glycosylation	1	run 368	UM_A_2013_0255_a2-KMS12.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0255_a2-KMS12.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-12	None	cell	None
Sample 123	Homo sapiens	peripheral blood	64Y	female	Multiple Myeloma	not available	B lymphocyte	KMS-12	glycosylation	1	run 369	UM_A_2013_0255_a3-KMS12.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0255_a3-KMS12.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-12	None	cell	None
Sample 124	Homo sapiens	peripheral blood	64Y	female	Multiple Myeloma	not available	B lymphocyte	KMS-12	glycosylation	2	run 370	UM_A_2013_0787_a1-KMS12.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0787_a1-KMS12.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-12	None	cell	None
Sample 124	Homo sapiens	peripheral blood	64Y	female	Multiple Myeloma	not available	B lymphocyte	KMS-12	glycosylation	2	run 371	UM_A_2013_0787_a2-KMS12.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0787_a2-KMS12.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-12	None	cell	None
Sample 124	Homo sapiens	peripheral blood	64Y	female	Multiple Myeloma	not available	B lymphocyte	KMS-12	glycosylation	2	run 372	UM_A_2013_0787_a3-KMS12.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0787_a3-KMS12.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-12	None	cell	None
Sample 125	Homo sapiens	peripheral blood	53Y	male	plasmacytoma	not available	B lymphocyte	U266	glycosylation	1	run 373	UM_A_2013_0788_a1-U266.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0788_a1-U266.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	U266	None	cell	None
Sample 125	Homo sapiens	peripheral blood	53Y	male	plasmacytoma	not available	B lymphocyte	U266	glycosylation	1	run 374	UM_A_2013_0788_a2-U266.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0788_a2-U266.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	U266	None	cell	None
Sample 125	Homo sapiens	peripheral blood	53Y	male	plasmacytoma	not available	B lymphocyte	U266	glycosylation	1	run 375	UM_A_2013_0788_a3-U266.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0788_a3-U266.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	U266	None	cell	None
Sample 126	Homo sapiens	peripheral blood	64Y	female	Multiple Myeloma	not available	B lymphocyte	KMS-12	glycosylation	3	run 376	UM_A_2013_0978_a1-KMS12.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0978_a1-KMS12.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-12	None	cell	None
Sample 126	Homo sapiens	peripheral blood	64Y	female	Multiple Myeloma	not available	B lymphocyte	KMS-12	glycosylation	3	run 377	UM_A_2013_0978_a2-KMS12.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0978_a2-KMS12.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-12	None	cell	None
Sample 126	Homo sapiens	peripheral blood	64Y	female	Multiple Myeloma	not available	B lymphocyte	KMS-12	glycosylation	3	run 378	UM_A_2013_0978_a3-KMS12.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0978_a3-KMS12.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-12	None	cell	None
Sample 127	Homo sapiens	peripheral blood	53Y	male	plasmacytoma	not available	B lymphocyte	U266	glycosylation	2	run 379	UM_A_2013_0979_a1-U266.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0979_a1-U266.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	U266	None	cell	None
Sample 127	Homo sapiens	peripheral blood	53Y	male	plasmacytoma	not available	B lymphocyte	U266	glycosylation	2	run 380	UM_A_2013_0979_a2-U266.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0979_a2-U266.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	U266	None	cell	None
Sample 127	Homo sapiens	peripheral blood	53Y	male	plasmacytoma	not available	B lymphocyte	U266	glycosylation	2	run 381	UM_A_2013_0979_a3-U266.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0979_a3-U266.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	U266	None	cell	None
Sample 128	Homo sapiens	peripheral blood	53Y	male	plasmacytoma	not available	B lymphocyte	U266	glycosylation	3	run 382	UM_A_2013_0980_a1-U266.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0980_a1-U266.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	U266	None	cell	None
